A detailed history of Shell Asset Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 4,055 shares of BIIB stock, worth $604,276. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,055
Previous 4,055 -0.0%
Holding current value
$604,276
Previous $940,000 16.38%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 31, 2024

SELL
$212.02 - $267.71 $57,033 - $72,013
-269 Reduced 6.22%
4,055 $940,000
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $665,318 - $840,073
-3,138 Reduced 42.05%
4,324 $932,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $540,893 - $651,094
2,430 Added 48.29%
7,462 $1.93 Million
Q3 2023

Nov 08, 2023

SELL
$253.3 - $285.89 $36,221 - $40,882
-143 Reduced 2.76%
5,032 $1.29 Million
Q2 2023

Jul 28, 2023

SELL
$275.25 - $318.06 $199,831 - $230,911
-726 Reduced 12.3%
5,175 $1.47 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $6,157 - $7,016
-24 Reduced 0.41%
5,901 $1.64 Million
Q4 2022

Feb 07, 2023

SELL
$252.44 - $306.72 $330,443 - $401,496
-1,309 Reduced 18.1%
5,925 $1.64 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $275,291 - $379,602
-1,414 Reduced 16.35%
7,234 $1.93 Million
Q2 2022

Aug 09, 2022

SELL
$187.54 - $223.02 $9,752 - $11,597
-52 Reduced 0.6%
8,648 $1.76 Million
Q1 2022

May 04, 2022

SELL
$193.77 - $244.14 $65,494 - $82,519
-338 Reduced 3.74%
8,700 $1.83 Million
Q4 2021

Feb 09, 2022

BUY
$223.92 - $287.77 $478,293 - $614,676
2,136 Added 30.95%
9,038 $2.17 Million
Q3 2021

Nov 04, 2021

SELL
$282.99 - $369.05 $14,432 - $18,821
-51 Reduced 0.73%
6,902 $1.95 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $1.4 Million - $2.24 Million
-5,408 Reduced 43.75%
6,953 $2.41 Million
Q1 2021

May 10, 2021

SELL
$242.95 - $284.63 $615,392 - $720,967
-2,533 Reduced 17.01%
12,361 $3.46 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $591,595 - $890,497
2,504 Added 20.21%
14,894 $3.65 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $8,737 - $10,088
-33 Reduced 0.27%
12,390 $3.52 Million
Q2 2020

Aug 10, 2020

BUY
$258.66 - $342.55 $795,379 - $1.05 Million
3,075 Added 32.89%
12,423 $3.32 Million
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $581,253 - $737,328
-2,162 Reduced 18.78%
9,348 $2.96 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $20,685 - $28,582
-94 Reduced 0.81%
11,510 $3.42 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $206,351 - $227,458
-941 Reduced 7.5%
11,604 $2.71 Million
Q1 2019

May 09, 2019

SELL
$216.71 - $338.96 $113,772 - $177,954
-525 Reduced 4.02%
12,545 $2.97 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $791,497 - $1 Million
-2,842 Reduced 17.86%
13,070 $3.93 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $12,327 - $16,120
42 Added 0.26%
15,912 $5.62 Million
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $506,026 - $603,078
1,965 Added 14.13%
15,870 $4.61 Million
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $2.54 Million - $3.59 Million
-9,769 Reduced 41.26%
13,905 $3.81 Million
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $1.02 Million - $1.14 Million
3,319 Added 16.31%
23,674 $7.54 Million
Q3 2017

Oct 20, 2017

SELL
$281.15 - $329.69 $5.21 Million - $6.11 Million
-18,527 Reduced 47.65%
20,355 $6.37 Million
Q3 2017

Oct 18, 2017

BUY
$281.15 - $329.69 $10.9 Million - $12.8 Million
38,882
38,882 $12.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.